Analyst Information for Actinium Pharmaceuticals Inc. (Delaware)

$ 0.4251 R     -0.0029 (-0.68%) Volume: 32.9m 4:00 PM EDT 7-Aug-2020
After Hours:  $ 0.39   -0.0351 (-8.26%) Volume: 4.31m 7:59 PM EDT 7-Aug-2020
Consensus Rating Average
Consensus Rating for ATNM is STRONG BUY
Since many brokers have different rating systems, we maintain a standard system with an assigned numeric value from 1 to 5. Ratings are a translation of brokers' recommendations to the recommendation scale, which ranges from a rating of 1 (a strong buy) to a rating of 5 (a strong sell).
Rating Scale
Strong Buy 1.0 - 1.5
Moderate Buy 1.6 - 2.5
Hold 2.6 - 3.5
Moderate Sell 3.6 - 4.5
Strong Sell 4.6 - 5.0
Consensus Rating Details
Current Average Recommendation 1.00
Previous Average Recommendation 1.00
Change in Average Recommendation 0.00
Number of Analysts Reporting 2
Strong Buy
1.0
Current: 1.00
Previous: 1.00
Change: 0.00
Strong Sell
5.0
Consensus Rating Industry Comparison
Industry: MED-DRUGS
Number of companies in industry with recommendations 188
Rank Recommendation relative to companies in its industry 45
Ranked 45 in Industry
1188 MED-DRUGS
Analyst Recommendations
Analysts recommending Strong Buy 2
Analysts recommending Moderate Buy 0
Analysts recommending Hold 0
Analysts recommending Moderate Sell 0
Analysts recommending Strong Sell 0
Vertical Bar Chart
Recommendations History
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.00 1.00 1.00 1.00

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.    RT = Real-Time,  EOD = End Of Day,  PD = Previous Day.   Market Data powered by QuoteMedia. Analyst ratings by Zacks.   Terms of Use.